Top compounds associated with response to LMAN2L


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib CCLE pan-cancer AAC -0.02 0.7
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.013 0.7
mRNA R428 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA myriocin CTRPv2 pan-cancer AAC -0.033 0.7
mRNA Pyrimethamine GDSC1000 pan-cancer AAC 0.021 0.7
mRNA Bortezomib FIMM pan-cancer AAC -0.06 0.7
mRNA SR1001 CTRPv2 pan-cancer AAC 0.016 0.7
Download CSV